SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

WFRF:(Merkely Béla)
 

Search: WFRF:(Merkely Béla) > Atrial high-rate ep...

Atrial high-rate episodes : prevalence, stroke risk, implications for management, and clinical gaps in evidence

Bertaglia, Emanuele (author)
Blank, Benjamin (author)
Blomström-Lundqvist, Carina (author)
Uppsala universitet,Kardiologi-arrytmi
show more...
Brandes, Axel (author)
Cabanelas, Nuno (author)
Dan, G-Andrei (author)
Dichtl, Wolfgang (author)
Goette, Andreas (author)
de Groot, Joris R (author)
Lubinski, Andrzej (author)
Marijon, Eloi (author)
Merkely, Béla (author)
Mont, Lluis (author)
Piorkowski, Christopher (author)
Sarkozy, Andrea (author)
Sulke, Neil (author)
Vardas, Panos (author)
Velchev, Vasil (author)
Wichterle, Dan (author)
Kirchhof, Paulus (author)
show less...
 (creator_code:org_t)
2019-08-03
2019
English.
In: Europace. - : Oxford University Press (OUP). - 1099-5129 .- 1532-2092. ; 21:10, s. 1459-1467
  • Research review (peer-reviewed)
Abstract Subject headings
Close  
  • Self-terminating atrial arrhythmias are commonly detected on continuous rhythm monitoring, e.g. by pacemakers or defibrillators. It is unclear whether the presence of these arrhythmias has therapeutic consequences. We sought to summarize evidence on the prevalence of atrial high-rate episodes (AHREs) and their impact on risk of stroke. We performed a comprehensive, tabulated review of published literature on the prevalence of AHRE. In patients with AHRE, but without atrial fibrillation (AF), we reviewed the stroke risk and the potential risk/benefit of oral anticoagulation. Atrial high-rate episodes are found in 10-30% of AF-free patients. Presence of AHRE slightly increases stroke risk (0.8% to 1%/year) compared with patients without AHRE. Atrial high-rate episode of longer duration (e.g. those >24 h) could be associated with a higher stroke risk. Oral anticoagulation has the potential to reduce stroke risk in patients with AHRE but is associated with a rate of major bleeding of 2%/year. Oral anticoagulation is not effective in patients with heart failure or survivors of a stroke without AF. It remains unclear whether anticoagulation is effective and safe in patients with AHRE. Atrial high-rate episodes are common and confer a slight increase in stroke risk. There is true equipoise on the best way to reduce stroke risk in patients with AHRE. Two ongoing trials (NOAH-AFNET 6 and ARTESiA) will provide much-needed information on the effectiveness and safety of oral anticoagulation using non-vitamin K antagonist oral anticoagulants in patients with AHRE.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Keyword

Anticoagulation
Atrial fibrillation
Atrial high-rate episodes
Continuous monitoring
Pacemaker
Stroke
Cardiology
Kardiologi

Publication and Content Type

ref (subject category)
for (subject category)

Find in a library

  • Europace (Search for host publication in LIBRIS)

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view